H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report)’s stock price crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares.
H. Lundbeck A/S Price Performance
The company’s fifty day moving average is $22.00 and its 200 day moving average is $22.00. The company has a quick ratio of 0.71, a current ratio of 1.15 and a debt-to-equity ratio of 0.32. The stock has a market cap of $21.91 billion, a PE ratio of 25.00 and a beta of 0.68.
H. Lundbeck A/S Company Profile
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Featured Stories
- Five stocks we like better than H. Lundbeck A/S
- 10 Best Airline Stocks to Buy
- CarMax’s Impressive Rally: What Investors Should Watch Next
- How to Calculate Options Profits
- MarketBeat Week in Review – 9/23 – 9/27
- Stock Dividend Cuts Happen Are You Ready?
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
